Schematic representation of the effects of concurrent treatment with an anti-CD19 mAb and FMC63 CD19 CAR effector cells in preclinical models.
Schematic representation of the effects of concurrent treatment with an anti-CD19 mAb and FMC63 CD19 CAR effector cells in preclinical models.
